Dr Lal Pathlabs Ltd EBITDA grew 9.5% YoY to ₹154 crore, though margins contracted slightly to 25.8% from 26.1% last year ...

The currency has been under pressure, thus stabilizing it involves injecting Rs 600 billion into banks through bond purchases ...

The industry hopes for more headroom for higher allocations for rural development schemes to pump up sales in smaller towns ...

Compared to 86.6250 in the previous session and flirting with the record low of 86.6475 hit almost two weeks ago, the 1-month ...

The company’s revenue for the quarter registered an increase of 116% y-o-y to ₹3,457 Crore as compared to ₹1,596 Crore.

However, despite excellent performance during the quarter, EBITDA margins declined to 6% in Q3FY25, against 7.1% in Q3FY24.

Adjusting for these one-time factors, operating revenue of Biocon grew 10% YoY to ₹3,821 crore, with total revenue increasing ...

Revenue increased 15% YoY at ₹1,153.7 crore from ₹1,005.8 crore in Q3 FY24, marking a consistent business growth.

GAIL (India) Ltd is the country’s largest gas distributor, which on Wednesday reported a strong Q3 FY25 performance after ...

Dabur India Ltd reported 4% organic domestic volume growth in Q3 FY25, while total volume growth including Badshah stood at 6 ...

The company registered a 28% increase in its December quarter’s Asset Under Management (AUM) at ₹3,98,043 Crore.

In order to balance their cost model, international players looked to India to establish their back-office operations ...